{
  "ptid_time": "129_S_6304_2018-04-16",
  "img_path": "/data/qiuhui/data/adni/images/129_S_6304/2018-04-16/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 12,026 mm³, 46.2% below the reference mean. With a Z-score of -1.16 (12.4th percentile), this represents mild atrophy; hippocampal volume measures 7,224 mm³, 6.0% below the reference mean. With a Z-score of -0.67 (25.1th percentile), this represents normal volume ; whole brain volume measures 874,001 mm³, 15.1% below the reference mean. With a Z-score of -1.88 (3.0th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,537 mm³, 9.1% below the reference mean. With a Z-score of -0.71 (23.9th percentile), this represents normal volume ; fusiform gyrus volume measures 13,690 mm³, 24.8% below the reference mean. With a Z-score of -2.80 (0.3th percentile), this represents significant atrophy; middle temporal gyrus volume measures 18,735 mm³, 8.7% below the reference mean. With a Z-score of -0.77 (22.0th percentile), this represents normal volume . ",
  "text_data": "Age is 66.3 years. Gender is Female. Education: 18 years. Handedness: Right. Race: Black or African American. MMSE: 30.0. MoCA: 30.0. Logical Memory: 16.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.10 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate whole-brain atrophy and significant fusiform gyrus atrophy, but hippocampal and entorhinal cortex volumes are within normal ranges. Despite these structural changes, cognitive testing (MMSE 30, MoCA 30) indicates no impairment, and amyloid PET (AV45) is normal.  \n\n**Diagnosis:** **CN (Cognitively Normal)**  \n**Confidence:** **Medium** (Structural atrophy without cognitive decline or amyloid pathology suggests possible early neurodegenerative changes, but current clinical presentation does not meet MCI/dementia criteria.)",
  "timestamp": "2025-07-26T14:19:15.062915"
}